The Association Between Oxidative Stress and Sperm Parameters in Patients with Acromegaly

Abstract

Objective Spermatozoa are susceptible to oxidative radicals when antioxidant defenses are inadequate. The extent to which oxidative radicals contribute to sperm damage in patients with acromegaly remains unclear. This study aimed to investigate and elucidate this relationship.

Methods The overall status of oxidants and antioxidants in both seminal plasma and serum of patients with acromegaly compared to a control group of healthy individuals was investigated. In addition, sperm parameters, including important measures such as growth hormone and insulin-like growth factor-1 concentrations.

Results Twenty-two patients with acromegaly with controlled disease and 14 healthy controls were included. The total oxidant status was significantly higher in the semen samples of the patients with acromegaly. A negative correlation was found between sperm total oxidant status and total sperm count and sperm concentration. Similarly, a negative correlation was found between the total sperm count and the sperm oxidative stress index. In individuals diagnosed with acromegaly, there was a statistically significant increase in sperm growth hormone levels. Conversely, the level of insulin-like growth factor 1 was significantly increased in the sperm of the control group, which consisted of healthy individuals. The correlation analysis revealed a significant relationship between venous total oxidant status and growth hormone levels in semen.

Conclusion The elevated levels of reactive oxygen radicals in individuals with acromegaly suggest a possible link between oxidative stress and its effects on semen quality.

Keywords

acromegaly - total oxidant status - growth hormone - semen sample

Publikationsverlauf

Eingereicht: 30. Januar 2024

Angenommen nach Revision: 26. März 2024

Artikel online veröffentlicht:
28. Juni 2024

• References

• 1 Giustina A, Biermasz N, Casanueva FF. et al. Acromegaly Consensus Group. Consensus on criteria for acromegaly diagnosis and remission. Pituitary 2024; 27: 7-22
• 2 Giustina A, Barkan A, Beckers A. et al. A Consensus on the diagnosis and treatment of acromegaly comorbidities: An update. J Clin Endocrinol Metab 2020; 105: dgz096
• 3 Chen Z, Yu Y, He M. et al. Higher growth hormone levels are associated with erectile dysfunction in male patients with acromegaly. Endocr Pract 2019; 25: 562-571
• 4 Andreassen M, Juul A, Feldt-Rasmussen U. et al. Semen quality in hypogonadal acromegalic patients. Pituitary 2020; 23: 160-166
• 5 Colao A, De Rosa M, Pivonello R. et al. Short-term suppression of GH and IGF-I levels improves gonadal function and sperm parameters in men with acromegaly. J Clin Endocrinol Metab 2002; 87: 4193-4197
• 6 Yilmaz MK, Sulu C, Ozkaya HM. et al. Evaluation of sex hormone profile and semen parameters in acromegalic male patients. J Endocrinol Investig 2021; 44: 2799-2808
• 7 Bardaweel SK, Gul M, Alzweiri M. et al. Reactive oxygen species: The dual role in physiological and pathological conditions of the human body. Eurasian J Med 2018; 50: 193-201
• 8 Colao A. The GH-IGF-I axis and the cardiovascular system: Clinical implications. Clin Endocrinol 2008; 69: 347-358
• 9 Higashi Y, Quevedo HC, Tiwari S. et al. Interaction between insulin-like growth factor-1 and atherosclerosis and vascular aging. Front Horm Res 2014; 43: 107-124
• 10 Maffei P, Dassie F, Wennberg A. et al. The endothelium in acromegaly. Front Endocrinol 2019; 10: 437
• 11 Bach LA. Endothelial cells and the IGF system. J Mol Endocrinol 2015; 54: R1-R13
• 12 Wolters TLC, Netea MG, Riksen NP. et al. Acromegaly, inflammation and cardiovascular disease: A review. Rev Endocr Metab Disord 2020; 21: 547-568
• 13 Agarwal A, Atikin RJ, Alvarez JG. et al. Studies on men’s health and fertility (oxidative stress in applied basic research and clinical practice). New York City, NY, USA: Humana Press; 2012
• 14 Agarwal A, Roychoudhury S, Bjugstad KB. et al. Oxidation-reduction potential of semen: What is its role in the treatment of male infertility?. Ther Adv Urol 2016; 8: 302-318
• 15 Agarwal A, Sharma RK, Nallella KP. et al. Reactive oxygen species as an independent marker of male factor infertility. Fertil Steril 2006; 86: 878-885
• 16 Valko M, Izakovic M, Mazur M. et al. Role of oxygen radicals in DNA damage and cancer incidence. Mol Cell Biochem 2004; 266: 37-56
• 17 Agarwal A, Hamada A, Esteves SC. Insight into oxidative stress in varicocele-associated male infertility: Part 1. Nat Rev Urol 2012; 9: 678-690
• 18 Hamada A, Esteves SC, Agarwal A. Insight into oxidative stress in varicocele-associated male infertility: Part 2. Nat Rev Urol 2013; 10: 26-37
• 19 Potts JM, Pasqualotto FF. Seminal oxidative stress in patients with chronic prostatitis. Andrologia 2003; 35: 304-308
• 20 Sabeti P, Pourmasumi S, Rahiminia T. et al. Etiologies of sperm oxidative stress. Int J Reprod Biomed (Yazd) 2016; 14: 231-240
• 21 Melmed S. Acromegaly pathogenesis and treatment. J Clin Investig 2009; 119: 3189-3202
• 22 Bhasin S, Cunningham GR, Hayes FJ. et al. Testosterone therapy in men with androgen deficiency syndromes: An Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2010; 95: 2536-2559
• 23 World Health organization. Laboratory manual for the examination and processing of human semen, 5th ed. Geneva: WHO Press; 2010
• 24 Erel O. A new automated colorimetric method for measuring total oxidant status. Clin Biochem 2005; 38: 1103-1111
• 25 Erel O. A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation. Clin Biochem 2004; 37: 277-285
• 26 Harma M, Erel O. Increased oxidative stress in patients with hydatidiform mole. Swiss Med Wkly 2003; 133: 563-566
• 27 Shoham Z, Conway GS, Ostergaard H. et al. Cotreatment with growth hormone for induction of spermatogenesis in patients with hypogonadotropic hypogonadism. Fertil Steril 1992; 57: 1044-1051
• 28 Carani C, Granata AR, De Rosa M. et al. The effect of chronic treatment with GH on gonadal function in men with isolated GH deficiency. Eur J Endocrinol/Eur Fed Endocr Soc 1999; 140: 224-230
• 29 Lee HS, Park YS, Lee JS. et al Serum and seminal plasma insulin-like growth factor-1 in male infertility. Clin Exp Reprod Med 2016; 43: 97-101 Epub 2016 Jun 23
• 30 Simopoulou M, Philippou A, Maziotis E. et al. Association between male Infertility and seminal plasma levels of growth hormone and insulin-like growth factor-1. Andrologia 2018; 50: e13048
• 31 Fu L, Yuen KCJ, Tint AN. et al. Association of decreased sperm motility and increased seminal plasma IGF-I, IGF-II, IGFBP-2, and PSA levels in infertile men. Endocrine 2021; 74: 698-706
• 32 Dutta S, Majzoub A, Agarwal A. Oxidative stress and sperm function: A systematic review on evaluation and management. Arab J Urol 2019; 17: 87-97
• 33 Takeshima T, Yumura Y, Yasuda K. et al. Inverse correlation between reactive oxygen species in unwashed semen and sperm motion parameters as measured by a computer-assisted semen analyzer. Asian J Androl 2017; 19: 350-354
• 34 Agarwal A, Rana M, Qiu E. et al Role of oxidative stress, infection and inflammation in male infertility. Andrologia 2018; 50: e13126 10.1111/and.13126
• 35 Majzoub A, Agarwal A. Systematic review of antioxidant types and doses in male infertility: Benefits on semen parameters, advanced sperm function, assisted reproduction and live-birth rate. Arab J Urol 2018; 16: 113-124
• 36 Magon N, Singh S, Saxena A. et al. Growth hormone in male infertility. Indian J Endocrinol Metab 2011; 15: S248-S249
• 37 Pedersen SA, Jørgensen JO, Christiansen JS. et al. Fertility and semen quality in previously growth hormone treated men. Pediatr Res 1988; 23: 120-120
• 38 Monzani ML, Pederzoli S, Volpi L. et al. Sexual dysfunction: A neglected and overlooked issue in adult GH deficiency: The management of AGHD study. J Endocrine Society 2021; 5: bvab002